Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-20

Clinical Trial Update: The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients

View source ↗

Summary

A clinical trial entry investigates the effect of alemtuzumab on the blood-brain barrier and brain metabolism in patients with multiple sclerosis. The current t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Multiple Sclerosis | Status: UNKNOWN